These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35619909)

  • 1. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer.
    Zhou L; Yu Y; Wen R; Zheng K; Jiang S; Zhu X; Sui J; Gong H; Lou Z; Hao L; Yu G; Zhang W
    Front Oncol; 2022; 12():863094. PubMed ID: 35619909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer.
    Xin C; Lai Y; Ji L; Wang Y; Li S; Hao L; Zhang W; Meng R; Xu J; Hong Y; Lou Z
    Front Genet; 2022; 13():1097234. PubMed ID: 36704343
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
    Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
    Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma.
    Feng Z; Qian H; Li K; Lou J; Wu Y; Peng C
    Front Mol Biosci; 2021; 8():676291. PubMed ID: 34095229
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
    Qian J; Zeng L; Jiang X; Zhang Z; Luo X
    Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
    Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
    J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Gene Expression Profiles Identifies a
    Chen Z; Chen M; Xue Z; Zhu X
    Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
    [No Abstract]   [Full Text] [Related]  

  • 12. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
    Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
    Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
    Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
    Front Oncol; 2021; 11():799223. PubMed ID: 35096599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
    Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
    Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
    Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
    Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.